Abstract:While the term artificial intelligence and the concept of deep learning are not new, recent advances in high-performance computing, the availability of large annotated data sets required for training, and novel frameworks for implementing deep neural networks have led to an unprecedented acceleration of the field of molecular (network) biology and pharmacogenomics. The need to align biological data to innovative machine learning has stimulated developments in both data integration (fusion) and knowledge representation, in the form of heterogeneous, multiplex, and biological networks or graphs. In this chapter we briefly introduce several popular neural network architectures used in deep learning, namely, the fully connected deep neural network, recurrent neural network, convolutional neural network, and the autoencoder. Deep learning predictors, classifiers, and generators utilized in modern feature extraction may well assist interpretability and thus imbue AI tools with increased explication, potentially adding insights and advancements in novel chemistry and biology discovery.The capability of learning representations from structures directly without using any predefined structure descriptor is an important feature distinguishing deep learning from other machine learning methods and makes the traditional feature selection and reduction procedures unnecessary. In this chapter we briefly show how these technologies are applied for data integration (fusion) and analysis in drug discovery research covering these areas: (1) application of convolutional neural networks to predict ligand–protein interactions; (2) application of deep learning in compound property and activity prediction; (3) de novo design through deep learning. We also: (1) discuss some aspects of future development of deep learning in drug discovery/chemistry; (2) provide references to published information; (3) provide recently advocated recommendations on using artificial intelligence and deep learning in -omics research and drug discovery.

Deep learning in modelling the protein–ligand interaction: new pathways in drug development

Deep Learning Frameworks for Protein–protein Interaction Prediction

Structure-based, deep-learning models for protein-ligand binding affinity prediction

Prediction of protein–ligand binding affinity via deep learning models

A new age in protein design empowered by deep learning

Deep Learning in Protein Structural Modeling and Design

Deep learning for protein structure prediction and design—progress and applications

Machine Learning for Sequence and Structure-Based Protein–Ligand Interaction Prediction

Deep learning techniques have significantly impacted protein structure prediction and protein design

AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges

Recent Applications of Deep Learning Methods on Evolution- and Contact-Based Protein Structure Prediction

The State-of-the-Art Overview to Application of Deep Learning in Accurate Protein Design and Structure Prediction

Structural modeling of antibody variable regions using deep learning—progress and perspectives on drug discovery

Deep Learning-Based Modeling of Drug–Target Interaction Prediction Incorporating Binding Site Information of Proteins

The rise of deep learning in drug discovery

Structure-based drug discovery with deep learning

Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology

Enhancing Drug-Target Binding Affinity Prediction through Deep Learning and Protein Secondary Structure Integration

A new paradigm for applying deep learning to protein–ligand interaction prediction

Advances in Protein-Ligand Binding Affinity Prediction via Deep Learning: A Comprehensive Study of Datasets, Data Preprocessing Techniques, and Model Architectures

3DProtDTA: a deep learning model for drug-target affinity prediction based on residue-level protein graphs